In the News December 12, 2016

Science | Under 21st Century Cures Legislation, Stem Cell Advocates Expect Regulatory Shortcuts

Marc Scheineson comments on the new Cures Act directing the U.S. Food and Drug Administration to approve drugs and devices with greater urgency.
Media Contact
Nicholas Clarke
Senior Communications Manager
Phone: 212.210.1222

This website uses cookies to improve functionality and performance. For more information, see our Privacy Statement. Additional details for California consumers can be found here.